Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

• Main Authors: Timothy Fitzgerald (Author), Maryia Zhdanava (Author), Dominic Pilon (Author), Aditi Shah (Author), Patrick Lefebvre (Author), Steven R. Feldman (Author)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Descrição do item

10.1007/s13555-023-01017-8
2193-8210
2190-9172